Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural features enable effective binding to specific enzyme active sites, enhancing selectivity and potency. The compound is also utilized in the preparation of bioactive molecules where the cyclopropane nitrile moiety contributes to metabolic stability and improved pharmacokinetic profiles. Additionally, it serves as a building block in medicinal chemistry for constructing fluorinated analogs to optimize drug candidates.